Department of Psychiatry, Oregon Health & Science University.
OHSU-PSU School of Public Health, Oregon Health & Science University.
Health Psychol. 2020 Sep;39(9):758-766. doi: 10.1037/hea0000870.
Preventive interventions for postpartum depression (PPD) are critical for women at elevated risk of PPD. Mindfulness based cognitive therapy - perinatal depression (MBCT-PD) is a preventive intervention that has been shown to reduce risk for PPD in women with a prior history of depression. The objective of this clinical trial is to examine two potential mechanisms of action of MBCT-PD, emotion regulation and cognitive control, using behavioral and neuroimaging methods.
This baseline protocol describes a randomized control trial (RCT) with two arms, MBCT-PD and treatment as usual (TAU). We plan on enrolling 74 females with a prior history of a major depressive episode, with 37 participants randomized to each arm. Participants in the MBCT-PD arm will receive MBCT-PD during pregnancy, and the TAU group will receive standard prenatal care. All participants will complete the Center for Epidemiological Studies Depression Scale - Revised (CESD-R), Emotion Regulation Questionnaire (ERQ), and classic Stroop task at multiple points from pregnancy through six months postpartum. Participants will also complete an fMRI scan at six weeks postpartum.
All primary outcomes are collected at six weeks postpartum. Primary behavioral outcomes include: depressive symptoms on the CESD-R, cognitive reappraisal on the ERQ, and Stroop task performance. In parallel, the primary neurobiological outcomes include whole-brain activation during fMRI tasks when participants 1) regulate emotional responding and 2) engage cognitive control.
This results of this innovative RCT will help identify potential behavioral and neurobiological mechanisms of action of preventive interventions for PPD for in-depth examination in larger scale RCTs. (PsycInfo Database Record (c) 2020 APA, all rights reserved).
针对产后抑郁症(PPD)风险较高的女性,预防干预措施至关重要。基于正念的认知疗法 - 围产期抑郁(MBCT-PD)是一种预防干预措施,已被证明可以降低有抑郁病史的女性患 PPD 的风险。本临床试验的目的是使用行为和神经影像学方法研究 MBCT-PD 的两个潜在作用机制,即情绪调节和认知控制。
本基线方案描述了一项随机对照试验(RCT),分为 MBCT-PD 组和常规治疗(TAU)组两个组。我们计划招募 74 名有过重度抑郁发作病史的女性,每组 37 名参与者。MBCT-PD 组的参与者将在怀孕期间接受 MBCT-PD,TAU 组将接受标准产前护理。所有参与者将在怀孕期间至产后六个月的多个时间点完成修订后的流行病学研究中心抑郁量表(CESD-R)、情绪调节问卷(ERQ)和经典 Stroop 任务。参与者还将在产后六周完成 fMRI 扫描。
所有主要结果均在产后六周收集。主要行为学结果包括:CESD-R 上的抑郁症状、ERQ 上的认知重评和 Stroop 任务表现。同时,主要神经生物学结果包括参与者在以下两种情况下的全脑激活:1)调节情绪反应和 2)进行认知控制时的 fMRI 任务。
这项创新 RCT 的结果将有助于确定预防干预措施针对 PPD 的潜在行为和神经生物学作用机制,以便在更大规模的 RCT 中进行深入研究。(PsycInfo 数据库记录(c)2020 APA,保留所有权利)。